SCHEMBL31228120

SCHEMBL31228120

C[C@]1(Cl)[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@](F)(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]1O

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ POLG P54098 2/20 0.49
▸ PNP P00491 1/20 0.48
▸ POLB P06746 3/20 0.46
▸ TGM2 P21980 1/20 0.46
▸ KRAS P01116 3/20 0.46
▸ FUT5 Q11128 1/20 0.45
▸ P2RY1 P47900 4/20 0.43
▸ P2RY2 P41231 2/20 0.43
▸ NT5E P21589 1/20 0.43
▸ P2RY4 P51582 1/20 0.43
▸ P2RY6 Q15077 1/20 0.43
▸ POLA1 P09884 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.41
▸ HPRT1 P00492 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15837371 0.92 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL15833120 0.92 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL20693182 0.92 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL18877607 0.92 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL15833114 0.92 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL15837393 0.92 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL21015822 0.91 PNP (0.50) POLGPNPPOLBTGM2KRAS
SCHEMBL18475782 0.88 POLG (0.48) POLGPNPPOLBTGM2KRAS
SCHEMBL22474912 0.87 POLG (0.51) POLGPNPPOLBTGM2KRAS
SCHEMBL19590226 0.87 POLG (0.51) POLGPNPPOLBTGM2KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback